COMPANY NEWS

3D Signatures Announces Change to Its Board of Directors

August 15, 2017
TORONTO, Aug. 11, 2017 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), announces that Helen Stevenson has...
Read More

3D SIGNATURES INC. ANNOUNCES SHORT FORM PROSPECTUS OFFERING TO RAISE UP TO C$5 MILLION

July 21, 2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON (July 19, 2017) −...
Read More

3D SIGNATURES ADVANCES HODGKIN’S LYMPHOMA TEST

June 8, 2017
TORONTO, ON (June 8, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

TeloView Measures Genomic Stability To Predict Disease Aggressiveness

May 15, 2017
TeloView Measures Genomic Stability To Predict Disease Aggressiveness Interview with Jason Flowerday READ FULL ARTICLE
Read More

3-D imaging of telomeres inside cells aids cancer diagnosis, treatment

May 8, 2017
3-D imaging of telomeres inside cells aids cancer diagnosis, treatment CEO Jason Flowerday explains how 3D Signatures technology can markedly...
Read More

3D SIGNATURES ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS

May 5, 2017
TORONTO, ON (May 5, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), announced today that Ferenc...
Read More

3D SIGNATURES RECEIVES FIRST PROSTATE CANCER BLOOD SAMPLES FOR PRECISE CLINICAL TRIAL

April 27, 2017
TORONTO, ON (April 27, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS") is pleased to announce...
Read More

How 3D Signatures’ technology helps detect Hodgkin’s lymphoma & Alzheimer’s

April 25, 2017
How 3D Signatures' technology helps detect Hodgkin’s lymphoma & Alzheimer’s 3D Signatures’ CEO Jason Flowerday shares the company’s latest progress...
Read More

3D SIGNATURES ANNOUNCES RELOCATION TO MARS DISCOVERY DISTRICT IN TORONTO

April 18, 2017
WINNIPEG, MB (April 18, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the “Company” or “3DS”), is pleased to announce that...
Read More

3D SIGNATURES ANNOUNCES APPOINTMENT OF DR. KEVIN LITTLE AS CHIEF SCIENTIFIC OFFICER

April 11, 2017
WINNIPEG, MB (April 11, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the “Company” or “3DS”), is pleased to announce...
Read More
1 2 3 7